Media

AAHI pioneers immune-enhancing platforms to provide potent, durable, broadly effective, and efficient vaccines and immunotherapies that are accessible to those who most need them.

NEWS & EVENTS

FILTER BY YEAR

Tiny, tough “water bears” may help bring new vaccines and medicines to sub-Saharan Africa

May 25, 2023

Leaps.org

Tuberculosis kills over a million people a year. New breakthroughs may help humanity fight back.

April 10, 2023

Freethink

Shark-Sourced Vaccine Ingredient May Be on Its Way Out

April 4, 2023

Technology Networks

AAHI Attends the World Vaccine Congress 2023 in Washington D.C.

March 27, 2023

AAHI

Local doctor helps develop potential tuberculosis vaccine. Here’s why it is so promising

March 7, 2023

The News Tribune

Page [tcb_pagination_current_page] of [tcb_pagination_total_pages]

First

Last

PRESS RELEASES

FILTER BY YEAR

AAHI Presents Advancements In Vaccine Formulations and Methodology at Modern Vaccines Adjuvant Delivery Systems Conference 2023

May 31, 2023

The Access to Advanced Health Institute Reports Encouraging Results of First-In-Human Trial of Its Temperature-Stable Tuberculosis Vaccine Candidate

March 6, 2023

The Access to Advanced Health Institute Announces $3M Award to Develop an Intranasal Pan-Viral Countermeasure against Respiratory Viruses

February 15, 2023

The Access to Advanced Health Institute Announces $9.9M Award to Develop a Nasal Spray Influenza RNA Vaccine Through Phase 1 Clinical Trials

February 6, 2023

AAHI Develops Longer Lasting and Broadly Protective SARS-CoV-2 RNA Vaccine Candidate that is Stable at Room Temperature

November 2, 2022

Page [tcb_pagination_current_page] of [tcb_pagination_total_pages]

First

Last